Found 10 matching trials
Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
Kendle International Inc.
Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
PHASE1This study will compare the relative bioavailability of 500 mg Divalproex S...
Location
PRACS Institute, Ltd.
Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ERĀ® Tablets 500 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
Cedra Clinical Research, LLC.
Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ERĀ® Tablets 500 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
Cedra Clinical Research, LLC.
Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions
PHASE1The purpose of this study is to assess the bioavailability of Divalproex So...
Location
Bioserve Clinical Research Pvt. Ltd.,
Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
PHASE1This study was designed to compare the relative bioavailability (rate and e...
Location
PRACS Institute, Ltd.
Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions
PHASE1The purpose of this study is to assess the bioavailability of Divalproex So...
Location
Bioserve Clinical Research Pvt. Ltd.,
Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
Kendle International Inc.
Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions
PHASE1This study will compare the relative bioavailability of 500 mg Divalproex S...
Location
PRACS Institute Ltd.
Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions
PHASE1This study will compare the relative bioavailability (rate and extent of ab...
Location
PRACS Institute, Ltd.